|

UCMYM802 Injection Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • UTC Therapeutics Inc.1

Indications

  • Malignant Mesothelioma1
  • Ovary Cancer1
  • Bile Duct Cancer1
  • Rectal Cancer1
  • Pancreatic Cancer1

Other1 trial

Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.